Chargement en cours...
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Despite recent therapeutic progress and improved survival for many patients with primary central nervous system lymphoma (PCNSL), up to 50% of patients will experience refractory or relapsed disease following first-line treatment with high dose methotrexate (HD-MTX) based regimens. The majority of s...
Enregistré dans:
| Publié dans: | Ann Lymphoma |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612457/ https://ncbi.nlm.nih.gov/pubmed/35253010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/aol-21-20 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|